What is it about?
Cardiac surgery has gone through major changes in improvement in surgical techniques and perioperative care but the risk prediction has been shown to be a moving target. Because of this, EuroSCORE investigators recently developed a revised version, the EuroSCORE II in October 2011, which was kept as simple as the original. Present findings suggest that EuroSCORE II is particularly accurate in predicting the operative mortality risk of high-risk patients, a weakness area of the original EuroSCORE. Though our cardiac center, IJN, has been using EuroSCORE II since 2012, it has yet to be validated.
Featured Image
Why is it important?
We wanted to validate EuroSCORE II in our population. Validating a model means to investigate its calibration and discrimination of a population under certain conditions. By using this model, we will be able to measure is a 30-day post-operative mortality; death within 30-days from operation or later if still in hospital; or late all-cause mortality.
Perspectives
This is an extensive study on 1718 patients operated in IJN during the period from 1st January 2016 until 31st December 2016 with a mortality rate of 4.66%. This study has proved that EuroSCORE II can be safely used for risk assessment in our patients and is a good predictor of post-operative mortality in the context of Malaysian patients undergoing CABG surgery.
Dato' Dr Ahmad Farouk Musa
Monash University
Read the Original
This page is a summary of: Validation of EuroSCORE II in patients undergoing coronary artery bypass grafting (CABG) surgery at the National Heart Institute, Kuala Lumpur: a retrospective review., F1000Research, May 2018, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.14760.1.
You can read the full text:
Contributors
The following have contributed to this page
